ESC Premium Access

Advances in Pathophysiology and Treatment of Hypertrophic Cardiomyopathy

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Hypertrophic Cardiomyopathy
Session type: Best ePosters
Date: 30 August 2020
Time: 08:30 - 08:30


4 presentations in this session

Lifetime mortality associated with hypertrophic cardiomyopathy: 28-year outcome of an historical cohort

Speaker: Mr N. Maurizi (Florence, IT)

What happens >10 years after percutaneous septal ablation for hypertrophic obstructive cardiomyopathy? Ultra long-term follow-up of 120 patients.

Speaker: Professor L. Faber (Bad Oeynhausen, DE)

Is alcohol septal ablation in women performed too late?

Speaker: Doctor A. Batzner (Wurzburg, DE)

High sensitivity troponin I in hypertrophic cardiomyopathy

Speaker: Doctor J. Osmanska (Glasgow, GB)

4 speakers from this session

Mr Niccolo' Maurizi

University of Florence, Florence (Italy)
0 follower

Professor Lothar Faber

Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen (Germany)
0 follower

Doctor Angelika Batzner

University Hospital of Wurzburg, Wurzburg (Germany)
0 follower

Doctor Joanna Osmanska

Golden Jubilee National Hospital, Glasgow (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk